| Name: | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate |
| CAS Number: | 75330-75-5 | 3D/inchi
|
| Other(deleted CASRN): | 71949-96-7 |
| FDA UNII: | 9LHU78OQFD |
| Nikkaji Web: | J22.276C |
| Beilstein Number: | 3631989 |
| MDL: | MFCD00072164 |
| XlogP3: | 4.30 (est) |
| Molecular Weight: | 404.54692000 |
| Formula: | C24 H36 O5 |
| BioActivity Summary: | listing |
| NMR Predictor: | Predict (works with chrome, Edge or firefox) |
Category:pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 174.50 °C. @ 760.00 mm Hg (est)
|
| Boiling Point: | 559.20 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 366.00 °F. TCC ( 185.30 °C. ) (est)
|
| logP (o/w): | 4.260 |
| Soluble in: |
| | water, 2.137 mg/L @ 25 °C (est) |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-child TDLo 17 mg/kg/3W-I BEHAVIORAL: WAKEFULNESS Lancet. Vol. 343, Pg. 973, 1994.
oral-human TDLo 8750 ug/kg/14D BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: WAKEFULNESS Clinical Pharmacology and Therapeutics Vol. 50, Pg. 730, 1991.
oral-man TDLo 240 mg/kg/60W- BEHAVIORAL: MUSCLE WEAKNESS Annals of Pharmacotherpy. Vol. 26, Pg. 190, 1992.
oral-mouse LD50 > 1000 mg/kg Journal of Antibiotics. Vol. 32, Pg. 852, 1979.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | pharmaceuticals / chemical synthisis |
| Recommendation for lovastatin usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for lovastatin flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
European Food Safety Authority (EFSA) reference(s):
|
Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the scientific substantiation of health claims related to monacolin K in SYLVAN BIO red yeast rice and maintenance of normal blood LDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006 View page or View pdf
|
Review of substances/agents that have direct beneficial effect on the environment: mode of action and assessment of efficacy View page or View pdf
|
Scientific Opinion on the substantiation of a health claim related to the combination of artichoke leaf dry extract standardised in caffeoylquinic acids, monacolin K in red yeast rice, sugar-cane derived policosanols, OPC from French maritime pine bark, garlic dry extract standardised in allicin, d-a-tocopheryl hydrogen succinate, riboflavin and inositol hexanicotinate in Limicol® and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006 View page or View pdf
|
| EPI System: View |
| ClinicalTrials.gov:search |
| Daily Med:search |
| Chemical Carcinogenesis Research Information System:Search |
| AIDS Citations:Search |
| Cancer Citations:Search |
| Toxicology Citations:Search |
| Carcinogenic Potency Database:Search |
| EPA ACToR:Toxicology Data |
| EPA Substance Registry Services (SRS):Registry |
| Laboratory Chemical Safety Summary :53232 |
| National Institute of Allergy and Infectious Diseases:Data |
| WGK Germany:3 |
| [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate |
| Chemidplus:0075330755 |
| RTECS:EK7907000 for cas# 75330-75-5 |
References:
| | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 53232 |
| Pubchem (sid): | 135011132 |
Other Information:
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| CHEBI: | View |
| CHEMBL: | View |
| KEGG (GenomeNet): | C07074 |
| HMDB (The Human Metabolome Database): | Search |
| Export Tariff Code: | 2922.50.1400 |
| MedlinePlusSupp: | View |
| ChemSpider: | View |
| Wikipedia: | View |
Formulations/Preparations: •oral tablets, 10 mg, 20 mg, 40 mg: lovastatin, geneva, teva; mevacor, merck
•lovalip, mevacor, mevinacor, mevlor, sivlor
|
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | altocor | | | altoprev | | | antibiotic MB 530B | | | butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S) | | | cholestra | | | colevix | | 2b,6a- | dimethyl-8a-(2-methyl-1-oxobutoxy)mevinic acid lactone | | (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a- | hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl (S)-2-Methylbutyrate | | | hipovastin | | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4- | hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate | | (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4- | hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate | | | lovastatinum | | 6-a- | methylcompactin | | | mevinacor | | | monacolin K | | | monakolin K | | | paschol |
Articles:
| PubMed:Antihepatoma and liver protective potentials of ganoderma lucidum ( ling zhi) fermented in a medium containing black soybean ( hÄ“i dòu) and astragalus membranaceus ( shÄ“ng huáng qÃ). |
| PubMed:Insights into Monascus biology at the genetic level. |
| PubMed:Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes. |
| PubMed:Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS. |
| PubMed:Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice. |
| PubMed:Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management. |
| PubMed:National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool. |
| PubMed:[Hypolipidemic agents drug interactions: approach to establish and assess its clinical significance. Structured review]. |
| PubMed:Several statins increase body and liver fat accumulation in a model of metabolic syndrome. |
| PubMed:Stability of monacolin K and citrinin and biochemical characterization of red-koji vinegar during fermentation. |
| PubMed:Effects of Monascus-fermented grain extracts on plasma antioxidant status and tissue levels of ubiquinones and α-tocopherol in hyperlipidemic rats. |
| PubMed:Strain improvement by overexpression of the laeA gene in Monascus pilosus for the production of monascus-fermented rice. |
| PubMed:Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms. |
| PubMed:Genome-scale reconstruction and in silico analysis of Aspergillus terreus metabolism. |
| PubMed:Exposure assessment of lovastatin in Pu-erh tea. |
| PubMed:Review of red yeast rice content and current Food and Drug Administration oversight. |
| PubMed:Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet. |
| PubMed:Development of a rapid LC/DAD/FLD/MS(n) method for the simultaneous determination of monacolins and citrinin in red fermented rice products. |
| PubMed:Simultaneous determination of lovastatin and citrinin in red yeast rice supplements by micellar electrokinetic capillary chromatography. |
| PubMed:Monascin and ankaflavin have more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity than monacolin K under the same dosages. |
| PubMed:Boceprevir: a recently approved protease inhibitor for hepatitis C virus infection. |
| PubMed:The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. |
| PubMed:Dietary Monascus adlay supplements facilitate suppression of cigarette smoke-induced pulmonary endoplasmic reticulum stress, autophagy, apoptosis and emphysema-related PLGF in the rat. |
| PubMed:Red mold dioscorea: a potentially safe traditional function food for the treatment of hyperlipidemia. |
| PubMed:What is a food and what is a medicinal product in the European Union? Use of the benchmark dose (BMD) methodology to define a threshold for "pharmacological action". |
| PubMed:A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class. |
| PubMed:Effect of hydroalcoholic extract of Hypericum perforatum on selected traditional and novel biochemical factors of cardiovascular diseases and atherosclerotic lesions in hypercholesterolemic rabbits: A comparison between the extract and lovastatin. |
| PubMed:A statin-regulated microRNA represses human c-Myc expression and function. |
| PubMed:The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes. |
| PubMed:Development of monacolin K-enriched ganghwayakssuk (Artemisia princeps Pamp.) by fermentation with Monascus pilosus. |
| PubMed:[Cholesterol-degrading in mice by Lactobacillus plantarum LpT1 and LpT2 in vivo]. |
| PubMed:NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements. |
| PubMed:Comparison of prescription drug costs in the United States and the United Kingdom, Part 1: statins. |
| PubMed:Cytotoxic dehydromonacolins from red yeast rice. |
| PubMed:Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms. |
| PubMed:Trillin, a steroidal saponin isolated from the rhizomes of Dioscorea nipponica, exerts protective effects against hyperlipidemia and oxidative stress. |
| PubMed:Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. |
| PubMed:Fast screening of lovastatin in red yeast rice products by flow injection tandem mass spectrometry. |
| PubMed:Antioxidant effect of red mould rice in hypercholesterolemic Wistar male rats. |
| PubMed:Osteoprotective effect of Monascus-fermented dioscorea in ovariectomized rat model of postmenopausal osteoporosis. |
| PubMed:Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. |
| PubMed:Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. |
| PubMed:Polysorbates as novel lipid-modulating candidates for reducing serum total cholesterol and low-density lipoprotein levels in hyperlipidemic C57BL/6J mice and rats. |
| PubMed:Inhibition of endothelial adhesion molecule expression by Monascus purpureus-fermented rice metabolites, monacolin K, ankaflavin, and monascin. |
| PubMed:Synchronous high-performance liquid chromatography with a photodiode array detector and mass spectrometry for the determination of citrinin, monascin, ankaflavin, and the lactone and acid forms of monacolin K in red mold rice. |
| PubMed:Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse. |
| PubMed:Chinese red yeast rice inhibition of prostate tumor growth in SCID mice. |
| PubMed:Elevated yield of monacolin K in Monascus purpureus by fungal elicitor and mutagenesis of UV and LiCl. |
| PubMed:d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. |
| PubMed:The effect of lovastatin on oxidative stress and antioxidant enzymes in hydrogen peroxide intoxicated rat. |
| PubMed:What combination therapy with a statin, if any, would you recommend? |
| PubMed:Marked variability of monacolin levels in commercial red yeast rice products: buyer beware! |
| PubMed:Conversion investigation for lovastatin and its derivatives by HPLC. |
| PubMed:Red yeast rice stimulates osteoblast proliferation and increases alkaline phosphatase activity in MC3T3-E1 cells. |
| PubMed:Finger millet (Eleusine coracana) - an economically viable source for antihypercholesterolemic metabolites production by Monascus purpureus. |
| PubMed:Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity. |
| PubMed:[With red rice against cholesterol?]. |
| PubMed:[Establishment of a model for evaluating hypolipidemic effect in HepG2 cells]. |
| PubMed:Major diet-drug interactions affecting the kinetic characteristics and hypolipidaemic properties of statins. |
| PubMed:Red mold rice promotes neuroprotective sAPPalpha secretion instead of Alzheimer's risk factors and amyloid beta expression in hyperlipidemic Abeta40-infused rats. |
| PubMed:Response surface methodology for optimization of production of lovastatin by solid state fermentation. |
| PubMed:Red Mold Rice Mitigates Oral Carcinogenesis in 7,12-Dimethyl-1,2-Benz[a]anthracene-Induced Oral Carcinogenesis in Hamster. |
| PubMed:Identification of the mokH gene encoding transcription factor for the upregulation of monacolin K biosynthesis in Monascus pilosus. |
| PubMed:Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism. |
| PubMed:The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells. |
| PubMed:A comparison of pectin, polyphenols, and phytosterols, alone or in combination, to lovastatin for reduction of serum lipids in familial hypercholesterolemic swine. |
| PubMed:Hypolipidemic effects of Monascus-fermented soybean extracts in rats fed a high-fat and -cholesterol diet. |
| PubMed:Effect of precultural and nutritional parameters on compactin production by solid-state fermentation. |
| PubMed:High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART). |
| PubMed:Concurrent use of statins and amiodarone. |
| PubMed:Safety evaluation of Monascus purpureus red mould rice in albino rats. |
| PubMed:d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. |
| PubMed:Red yeast rice fermentation by selected Monascus sp. with deep-red color, lovastatin production but no citrinin, and effect of temperature-shift cultivation on lovastatin production. |
| PubMed:Effects of rutin on lipid profile in hypercholesterolaemic rats. |
| PubMed:Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. |
| PubMed:Compactin production studies using Penicillium brevicompactum under solid-state fermentation conditions. |
| PubMed:Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression. |
| PubMed:Defective rotavirus particle assembly in lovastatin-treated MA104 cells. |
| PubMed:Grapefruit juice-drug interaction studies as a method to assess the extent of intestinal availability: utility and limitations. |
| PubMed:SREBP-2 regulates gut peptide secretion through intestinal bitter taste receptor signaling in mice. |
| PubMed:An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system. |
| PubMed:Comparative evaluation of the hypolipidemic effects of coconut water and lovastatin in rats fed fat-cholesterol enriched diet. |
| PubMed:Red mold rice prevents the development of obesity, dyslipidemia and hyperinsulinemia induced by high-fat diet. |
| PubMed:Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. |
| PubMed:Cloning and characterization of monacolin K biosynthetic gene cluster from Monascus pilosus. |
| PubMed:The safety of niacin in the US Food and Drug Administration adverse event reporting database. |
| PubMed:Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention. |
| PubMed:Mevinolin, citrinin and pigments of adlay angkak fermented by Monascus sp. |
| PubMed:Fixed-dose combination therapy with statins: strengths, limitations, and clinical and regulatory considerations. |
| PubMed:Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and antioxidative effect. |
| PubMed:The Food and Drug Administration and over-the-counter statins: an opportunity lost? |
| PubMed:FDA advisers again reject nonprescription lovastatin. |
| PubMed:A simple and rapid approach for removing citrinin while retaining monacolin K in red mold rice. |
| PubMed:The potential antioxidant capacity and angiotensin I-converting enzyme inhibitory activity of Monascus-fermented soybean extracts: evaluation of Monascus-fermented soybean extracts as multifunctional food additives. |
| PubMed:Monascus rice products. |
| PubMed:Optimization of production of monacolin K from gamma-irradiated Monascus mutant by use of response surface methodology. |
| PubMed:Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells. |
| PubMed:Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. |
| PubMed:Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters. |
| PubMed:Improving the ratio of monacolin K to citrinin production of Monascus purpureus NTU 568 under dioscorea medium through the mediation of pH value and ethanol addition. |
| PubMed:Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. |
| PubMed:Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. |
| PubMed:Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). |
| PubMed:Influences of lovastatin on membrane ion flow and intracellular signaling in breast cancer cells. |
| PubMed:Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain. |
| PubMed:Proteomic analysis of Caco-2 cells treated with monacolin K. |
| PubMed:Synchronous analysis method for detection of citrinin and the lactone and acid forms of monacolin K in red mold rice. |
| PubMed:Grape fruit juice-drug interactions. |
| PubMed:Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. |
| PubMed:Enzymatic examination of potential interaction between statins or fibrates and consumed Tricholoma equestre. |
| PubMed:Risks of a nonprescription lovastatin. |
| PubMed:Study on red fermented rice with high concentration of monacolin K and low concentration of citrinin. |
| PubMed:Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. |
| PubMed:FDA advisers vote against nonprescription lovastatin. |
| PubMed:OTC status for low-dose lovastatin would have widespread implications. |
| PubMed:Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats. |
| PubMed:Modified mutation method for screening low citrinin-producing strains of Monascus purpureus on rice culture. |
| PubMed:Interactions between grapefruit juice and cardiovascular drugs. |
| PubMed:Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. |
| PubMed:Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry. |
| PubMed:The role of maternal toxicity in lovastatin-induced developmental toxicity. |
| PubMed:Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. |
| PubMed:Evaluation of hesperetin 7-O-lauryl ether as lipid-lowering agent in high-cholesterol-fed rats. |
| PubMed:Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates. |
| PubMed:Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition. |
| PubMed:Effect of red mold rice supplements on serum and egg yolk cholesterol levels of laying hens. |
| PubMed:Methyl palmitate: a novel product of the Medfly (Ceratitis capitata) corpus allatum. |
| PubMed:Cinnamate supplementation enhances hepatic lipid metabolism and antioxidant defense systems in high cholesterol-fed rats. |
| PubMed:[Effect of lovastatin on the expression of IkappaBalpha and cell-cycle regulating protein in MCF-7 cells]. |
| PubMed:Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females. |
| PubMed:Statin-associated memory loss: analysis of 60 case reports and review of the literature. |
| PubMed:Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. |
| PubMed:Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits. |
| PubMed:Biosynthetic maturation of the corpus allatum of the female adult medfly, Ceratitis capitata, and its putative control. |
| PubMed:4-hydroxycinnamate lowers plasma and hepatic lipids without changing antioxidant enzyme activities. |
| PubMed:Lopinavir/ritonavir: a review of its use in the management of HIV infection. |
| PubMed:[Effects of lovastatin on proliferation and gap junctional intercellular communication of human breast cancer cell MCF-7]. |
| PubMed:Effect of rice--glycerol complex medium on the production of Lovastatin by Monascus ruber. |
| PubMed:Side effects of statins--prevalence, relevance, consequences. |
| PubMed:[Effect of monascus on improving the hemorheology of rats with high blood lipids]. |
| PubMed:Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia. |
| PubMed:A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. |
| PubMed:Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen. |
| PubMed:Alterations in membrane-bound and cytoplasmic K-ras protein levels in mouse lung induced by treatment with lovastatin, cholestyramine, or niacin: effects are highly mouse strain dependent. |
| PubMed:Food-drug interactions. |
| PubMed:From the Food and Drug Administration. |
| PubMed:Managing dyslipidemia in the high-risk patient. |
| PubMed:CD43 polarization in unprimed T cells can be dissociated from raft coalescence by inhibition of HMG CoA reductase. |
| PubMed:FDA adverse event reports on statin-associated rhabdomyolysis. |
| PubMed:Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans. |
| PubMed:Lipid-lowering and antioxidative activities of 3,4-di(OH)-cinnamate and 3,4-di(OH)-hydrocinnamate in cholesterol-fed rats. |
| PubMed:The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins. |
| PubMed:Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer. |
| PubMed:FDA panel vetoes OTC version of cholesterol drug. |
| PubMed:Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents. |
| PubMed:[Effect of cholesterol deficiency on the membrane fluidity of Jurkat T lymphocytes]. |
| PubMed:New OTC drugs and devices 2000: a selective review. |
| PubMed:Cardiovascular risk factors and testing of relatives amongst patients with familial hyperlipidaemia one decade after a clinical trial. |
| PubMed:FDA says statin cannot be sold over the counter. |
| PubMed:Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait. |
| PubMed:Grapefruit juice-lovastatin interaction. |
| PubMed:Defining patient risks from expanded preventive therapies. |
| PubMed:Evidence that MRas1 and MRas3 proteins are associated with distinct cellular functions during growth and morphogenesis in the fungus Mucor racemosus. |
| PubMed:Effect of dietary lipid-lowering drugs upon plasma lipids and egg yolk cholesterol levels of laying hens. |
| PubMed:Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. |
| PubMed:Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus. |
| PubMed:Cost-effectiveness of statins. |
| PubMed:Grapefruit juice-drug interactions. |
| PubMed:Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. |
| PubMed:The role of nutritional modifications in the prevention of macrovascular complications of diabetes. |
| PubMed:FDA and Pharmanex clash over dietary supplement. |
| PubMed:Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. |
| PubMed:Simvastatin further enhances the hypocholesterolemic effect of soy protein in rabbits. |
| PubMed:Biochemical characterization of the phagocytic giant cell receptor for Dictyostelium discoideum amoebae: identification by cell blotting. |
| PubMed:The effect of ethanol and/or food restriction on coenzyme Q in liver in rats. |
| PubMed:Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood. |
| PubMed:The effect of manganese-induced hypercholesterolemia on learning in rats. |
| PubMed:Development and pharmacology of fluvastatin. |
| PubMed:Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors. |
| PubMed:Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. |
| PubMed:Reversibility of manganese-induced learning defect in rats. |
| PubMed:Effect of lovastatin on cholesterol content of cardiac and red blood cell membranes in normal and cardiomyopathic hamsters. |
| PubMed:In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin. |
| PubMed:Development and pharmacology of fluvastatin. |
| PubMed:Clinical pharmacokinetics of pravastatin. |
| PubMed:Clinical implications of the biopharmaceutical properties of fluvastatin. |
| PubMed:Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. |
| PubMed:In vivo regulation of hepatic lipase activity and mRNA levels by diets which modify cholesterol influx to the liver. |
| PubMed:Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. |
| PubMed:Effects of ethanol, lovastatin and coenzyme Q10 treatment on antioxidants and TBA reactive material in liver of rats. |
| PubMed:Plasma VLDL cholesterol and egg cholesterol are resistant to change in the laying hen. |
| PubMed:HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. |
| PubMed:RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent. |
| PubMed:Studies on the effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the rodent forestomach. |
| PubMed:Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients. |
| PubMed:Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer barrier function. |
| PubMed:Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor). |
| PubMed:Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. |
| PubMed:Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. |
| PubMed:Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits. |
| PubMed:Effects of lovastatin and leupeptin on ceroidogenesis of vitamin E-deficient and -supplemented young rats. |
| PubMed:Lovastatin is hypertriglyceridemic in Syrian golden hamsters. |
| PubMed:Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. |
| PubMed:The effect of cholestyramine and Mevinolin on the diurnal cycle of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. |
| PubMed:Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia. |
|